Home » Newsletters » BioWorld Asia

BioWorld Asia

March 10, 1999

View Archived Issues

Amrad Sells Baxter Rights To Heart Protein For $22M

NeuroSearch, P&U Ending Deal On Anxiety Treatment

On-The-Spot Tests Could Let Physicians Identify Genotype, Determine Strongest Treatment

Oxford Ends Year Strong; Deals Fuel Cash Position

Inpharmatica Raises #3M In Second Financing Round

RPR Joins Genetics Institute Roster Of Database Buyers

Axis, Roche Join Forces To Test Animal Vaccines

Chiroscience Regains Rights To Lead Anesthetic Product

Actinova In Three-Way Pact For Streptococcus Vaccine

Oxford BioMedica Raising #3.6M For Cancer Study

SR Pharma, Corixa Enter Second Licensing Deal

Stocks Follow Biota Slide After Flu Drugs Refusal

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Aug. 29, 2025.
Sideroflexin 1 is potential therapeutic target in bladder cancer
BioWorld Science
Bladder cancer is among the 10 most frequent cancers around the world. While potentially effective treatments exist, they do not benefit all patients, so...
Industry looking to adapt under shadow of US Rx tariffs
BioWorld
While U.S. President Donald Trump’s country-by-country reciprocal and newly negotiated tariffs go into effect today, a separate, global biopharma sector tariff...
Serum α-1-microglobulin is biomarker in aortic valve stenosis
BioWorld Science
Calcific aortic valve disease (CAVD) is the most prevalent acquired valve heart disorder in aging populations. Its most severe form in aortic valve stenosis...